Related references
Note: Only part of the references are listed.Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children
Denis F. Noubouossie et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease
Abdullah Kutlar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
P-selectin glycoprotein ligand-1 inhibition blocks increased leukocyte-endothelial interactions associated with sickle cell disease in mice
Wei Luo et al.
BLOOD (2012)
Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease
Pichika Chantrathammachart et al.
BLOOD (2012)
Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation
Roxane Darbousset et al.
BLOOD (2012)
Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease
Vanessa T. Garrido et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients With Sickle Cell Disease
M. H. Qari et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2012)
New insights into the mechanisms of venous thrombosis
Nigel Mackman
JOURNAL OF CLINICAL INVESTIGATION (2012)
Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa
P. E. J. van der Meijden et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Pulmonary embolism in sickle cell disease: a case-control study
E. M. Novelli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia
M. P. Colella et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease
Kenneth I. Ataga et al.
PLOS ONE (2012)
The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles
Grigoris T. Gerotziafas et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Spatiotemporal Dysfunction of the Vascular Permeability Barrier in Transgenic Mice with Sickle Cell Disease
Samit Ghosh et al.
ANEMIA (2012)
Pulmonary Artery Thrombosis during Acute Chest Syndrome in Sickle Cell Disease
Armand Mekontso Dessap et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease
Diana R. Gutsaeva et al.
BLOOD (2011)
Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S
Felicity N. E. Gavins et al.
BLOOD (2011)
The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma
Junmei Chen et al.
BLOOD (2011)
A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction
Carolyn Hoppe et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Microparticles in Hemostasis and Thrombosis
A. Phillip Owens et al.
CIRCULATION RESEARCH (2011)
Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability
M. M. Aleman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation
Leylla Badeanlou et al.
NATURE MEDICINE (2011)
Thrombosis and Sickle Cell Disease
Lucia De Franceschi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2011)
P-Selectin-Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease
Renata Polanowska-Grabowska et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13
Junmei Chen et al.
BLOOD (2010)
Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice
Rafal Pawlinski et al.
BLOOD (2010)
The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice
Robert P. Hebbel et al.
BLOOD (2010)
Increased adhesive properties of platelets in sickle cell disease: roles for αIIbβ3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity
Renata Proenca-Ferreira et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Live/Real Time Three-Dimensional Transthoracic Echocardiographic Assessment of Inferior Vena Cava and Hepatic Vein Thrombosis in Sickle Cell Disease
Balwinder Singh et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2010)
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
James E. Bradner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Nuclear factor-kappa B (NFκB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease
Rahn Kollander et al.
TRANSLATIONAL RESEARCH (2010)
D-dimer antigen: current concepts and future prospects
Soheir S. Adam et al.
BLOOD (2009)
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-γ and CXCR3 chemokines
Kori L. Wallace et al.
BLOOD (2009)
Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease
Eduard J. van Beers et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Hypercoagulability and thrombotic complications in hemolytic anemias
Kenneth I. Ataga
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury
Andres Hidalgo et al.
NATURE MEDICINE (2009)
Hypercoagulability in Sickle Cell Disease and Beta-Thalassemia
Sylvia T. Singer et al.
CURRENT MOLECULAR MEDICINE (2008)
No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension
E. J. van Beers et al.
HAEMATOLOGICA (2008)
Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia
B. N. Y. Setty et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia
Suba Krishnan et al.
THROMBOSIS RESEARCH (2008)
Mouse models of sickle cell disease
Y. Beuzard
TRANSFUSION CLINIQUE ET BIOLOGIQUE (2008)
Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension
Kenneth Ataga et al.
HAEMATOLOGICA (2007)
Fibrinogen deficiency, but not plasminogen deficiency, increases mortality synergistically in combination with sickle hemoglobin SAD in transgenic mice
Nancy J. Roszell et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Histone deacetylase inhibitors suppress TF-κB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes
Jianguo Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors
Barbara N. Porto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis
Nigel Mackman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Characterization of heme as activator of toll-like receptor 4
Rodrigo T. Figueiredo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
Gregory J. Kato et al.
BLOOD REVIEWS (2007)
The role of von Willebrand factor in thrombus formation
Zaverio M. Ruggeri
THROMBOSIS RESEARCH (2007)
Sickle cell disease: old discoveries, new concepts, and future promise
Paul S. Frenette et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves γ-globin activation by CREB1 and ATF-2
Jose Sangerman et al.
BLOOD (2006)
Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease
Paul D. Stein et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Correction of sickle cell disease by homologous recombination in embryonic stem cells
Li-Chen Wu et al.
BLOOD (2006)
Biologically active CD40 ligand is elevated in sickle cell anemia - Potential role for platelet-mediated inflammation
Sheritha P. Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality
AH James et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease
CR Morris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation
JS Mohan et al.
BLOOD COAGULATION & FIBRINOLYSIS (2005)
The fibrin-derived peptide Bβ15-42 protects the myocardium against ischemia-reperfusion injury
P Petzelbauer et al.
NATURE MEDICINE (2005)
Pathophysiology of stroke in sickle cell disease
CA Hillery et al.
MICROCIRCULATION (2004)
Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin
A Solovey et al.
BLOOD (2004)
Cytokine profile of sickle cell disease in Oman
A Pathare et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo
SH Embury et al.
BLOOD (2004)
Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes
AS Shet et al.
BLOOD (2003)
Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation
L de Franceschi et al.
BLOOD (2003)
Portal vein thrombosis following laparoscopic surgery in a patient with sickle cell disease
PCH Ng et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2003)
Effect of hydroxyurea on mortality. and morbidity in adult sickle cell anemia - Risks and benefits up to 9 years of treatment
MH Steinberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions
JF Dong et al.
BLOOD (2002)
Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin
NM Matsui et al.
BLOOD (2002)
Sickle cell disease: The neurological complications
M Prengler et al.
ANNALS OF NEUROLOGY (2002)
Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm
A Turhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Sickle cell vaso-occlusion: multistep and multicellular paradigm
PS Frenette
CURRENT OPINION IN HEMATOLOGY (2002)
Thrombophilia in sickle cell disease: the red cell connection
BNY Setty et al.
BLOOD (2001)
Low adjusted-dose acenocoumarol therapy in sickle cell disease: A pilot study
JB Schnog et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase
FADTG Wagener et al.
BLOOD (2001)
Thrombogenesis in sickle cell disease
A Tomer et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin
E Dupuy et al.
THROMBOSIS RESEARCH (2001)
Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression
E Lindmark et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
E Camerer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
